Asymmetry of pathology in Alzheimer's disease.

Asymmetry of pathology in Alzheimer's disease.

Bibliographic Details
Main Authors:	Wilcock, G, Esiri, M
Format:	Journal article
Language:	English
Published:	BMJ Publishing Group 1987

Similar Items

Pathologic diagnosis of Alzheimer's.
by: Köster, R, et al.
Published: (1989)

Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer disease.
by: Pearson, R, et al.
Published: (1985)

Age and Alzheimer's disease.
by: Wilcock, G, et al.
Published: (1983)

Coexisting pathologies in the brain: influence of vascular disease and Parkinson's disease on Alzheimer's pathology in the hippocampus.
by: Smith, M, et al.
Published: (2000)

The olfactory bulbs in Alzheimer's disease.
by: Esiri, M, et al.
Published: (1984)

Loss of perineuronal nets in Alzheimer's disease is not related to tau pathology
by: Baig, S, et al.
Published: (2004)

Relationship of neurofibrillary pathology to cerebral amyloid angiopathy in Alzheimer's disease.
by: Williams, S, et al.
Published: (2005)

Relationship of neurofibrillary pathology to cerebral amyloid angiopathy in Alzheimer's disease
by: Williams, S, et al.
Published: (2005)

Decreased CSF acetylcholinesterase activity in Alzheimer's disease.
by: Appleyard, M, et al.
Published: (1983)

Vulnerability to Alzheimer's pathology in neocortex: The roles of plasticity and columnar organization
by: Esiri, M, et al.
Published: (2006)

Vulnerability to Alzheimer's pathology in neocortex: the roles of plasticity and columnar organization.
by: Esiri, M, et al.
Published: (2006)

Vulnerability to Alzheimer's pathology in neocortex: The roles of plasticity and columnar organization
by: Esiri, M, et al.
Published: (2006)

Immunoglobulin and other proteins in the cerebrospinal fluid of patients with Alzheimer's disease.
by: Chapel, H, et al.
Published: (1984)

Constructional apraxia in Alzheimer's disease: association with occipital lobe pathology and accelerated cognitive decline.
by: Smith, M, et al.
Published: (2001)

Cerebral subcortical small vessel disease in subjects with pathologically confirmed alzheimer disease: A clinicopathologic study in the oxford project to investigate memory and ageing (OPTIMA)
by: Esiri, M, et al.
Published: (2014)

Cerebral subcortical small vessel disease in subjects with pathologically confirmed Alzheimer disease: a clinicopathologic study in the Oxford Project to Investigate Memory and Ageing (OPTIMA).
by: Esiri, M, et al.
Published: (2014)

Synaptic pathology in prefrontal cortex is present only with severe dementia in Alzheimer disease.
by: Minger, S, et al.
Published: (2001)

Treatment for Alzheimer's disease.
by: Wilcock, G
Published: (2000)

Neurotrophins in Alzheimer's disease
by: Wilcock, G
Published: (2002)

SOME OBSERVATIONS ON THE DISTRIBUTION OF CORTICAL TANGLES IN ALZHEIMERS-DISEASE
by: Esiri, M, et al.
Published: (1985)

The nucleus basalis in Alzheimer's disease: cell counts and cortical biochemistry.
by: Wilcock, G, et al.
Published: (1983)

Monoaminergic innervation of the frontal and temporal lobes in Alzheimer's disease.
by: Palmer, A, et al.
Published: (1987)

Galantamine in Alzheimer's disease.
by: Razay, G, et al.
Published: (2008)

Hyperinsulinaemia and Alzheimer's disease.
by: Razay, G, et al.
Published: (1994)

Treating Alzheimer's disease.
by: Wilcock, G, et al.
Published: (1995)

Velnacrine for Alzheimer's disease.
by: Birks, J, et al.
Published: (2004)

TACRINE AND LECITHIN IN ALZHEIMERS-DISEASE
by: Wilcock, G
Published: (1990)

Alzheimer's disease--current issues.
by: Wilcock, G
Published: (1988)

Blood-based proteomic biomarkers of Alzheimer’s disease pathology
by: Baird, A, et al.
Published: (2015)

The effects of cell cycle progression and Alzheimer-type pathology on cognitive decline
by: Smith, M, et al.
Published: (2000)

Neurotransmitter dysfunction and atrophy of the caudate nucleus in Alzheimer's disease.
by: Pearce, B, et al.
Published: (1984)

Non-immunoglobin in cerebrospinal fluid of patients with Alzheimer's disease and cerebral amyloid angiopathy.
by: Esiri, M, et al.
Published: (1985)

APOE epsilon 4 influences the pathological phenotype of Alzheimer's disease by favouring cerebrovascular over parenchymal accumulation of A beta protein.
by: Chalmers, K, et al.
Published: (2003)

The increasing burden of Alzheimer disease.
by: Sadik, K, et al.
Published: (2003)

Current approaches to the treatment of Alzheimer's disease.
by: Wilcock, G
Published: (1996)

Treatment of the cholinergic impairment in Alzheimer's disease
by: Wilcock, G
Published: (1994)

Bapineuzumab in Alzheimer's disease: where now?
by: Wilcock, G
Published: (2010)

Alzheimer's disease. Correlation of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalities.
by: Wilcock, G, et al.
Published: (1982)

THE RELATIONSHIP OF ARGYROPHILIC PLAQUES AND NEUROFIBRILLARY TANGLES TO THE SEVERITY OF DEMENTIA AND CORTICAL CHOLINE ACETYL TRANSFERASE LEVELS IN ALZHEIMERS-DISEASE
by: Wilcock, G, et al.
Published: (1983)

Modelling cerebrovascular pathology and the spread of amyloid beta in Alzheimer’s disease
by: Ahern, A, et al.
Published: (2025)